No verdict after 4th day of deliberations in Shkreli trial

Business Leaders Associated Press

FILE - In this Thursday, July 27, 2017, file photo, former biotech CEO Martin Shkreli, center, leaves federal court with his attorney Benjamin Brafman, left, in New York. A jury began deliberations Monday, July 31, 2017, at Shkreli's federal ... securities fraud trial. (AP Photo/Julie Jacobson, File) (AP)

NEW YORK (AP) — Jurors have failed to reach a verdict after the fourth day of deliberations in the securities fraud trial of former pharmaceutical company CEO Martin Shkreli.

Continue Reading Below

Deliberations will resume Friday in federal court in New York City.

Prosecutors say Shkreli looted his drug company to pay back investors in two failed hedge funds he ran. The defense says investors got their original investments back and even made hefty profits.

The former biotech CEO, nicknamed "Pharma Bro," is best known for hiking up the price of a life-saving drug and for trolling his critics on social media.

If convicted of the most serious charges, he could face up to 20 years in prison, but likely would receive far less time under sentencing guidelines.

What do you think?

Click the button below to comment on this article.